Research Community
GP2's Research Community
GP2 is a product and a source of collaboration. The individuals and groups that contribute to GP2 drive its strategy, its operations, and ultimately its impact. Read more.
Training
Training
At GP2, we are committed to creating a global research community with the tools and infrastructure to address emerging research needs and questions. Read more.
Data Resources
Data Resources
GP2 develops and maintains tools that assemble clinical and genetic data to help accelerate research across the Parkinson’s Disease Research community. Read more.

Emma Somerville, BSc

Centogene

Ottawa, Ontario, Canada

Area of Focus

GBA1
Genetics of Parkinson’s
Biomarker
Gene prioritization
Gene-pesticide exposure interaction
Functional genomics
Genetics
Neurodegeneration
Polygenic Risk Score (PRS)
Genetic Modifiers

Biography

Emma is a Research Scientist at Centogene who specializes in computationally analyzing how genetics can inform disease risk or impact biomarker variability. She completed her PhD at McGill University where she studied the genetic determinants of Parkinson’s disease biomarkers and the prodromal synucleinopathy REM-sleep behaviour disorder.